Stay updated on Dupilumab in Chronic Urticaria Clinical Trial

Sign up to get notified when there's something new on the Dupilumab in Chronic Urticaria Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dupilumab in Chronic Urticaria Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Revision: v3.5.2 was added and v3.5.0 removed. This is a site version update that does not modify study content or user actions.
    Difference
    0.1%
    Check dated 2026-04-16T11:41:17.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    Revision tag on the page updated to v3.5.0, replacing the previous v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-18T21:16:47.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Revision: v3.4.3 has been added, replacing the previous Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T18:20:41.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and the prior government funding notice along with Revision: v3.4.1 were removed; this appears to be a site-wide administrative update rather than a change to study information.
    Difference
    0.4%
    Check dated 2026-02-11T06:25:15.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    Added a site-wide notice about a lapse in government funding and updated the site revision to v3.4.1 (from v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T05:12:38.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    Glossary display added and QC-related metadata updated (Last Update Submitted that Met QC Criteria) along with a site revision indicator (Revision: v3.4.0); the previous phrasing variant (Last Update Submitted that met QC Criteria) and 'No FEAR Act data' wording were removed.
    Difference
    0.2%
    Check dated 2026-01-28T03:24:49.000Z thumbnail image

Stay in the know with updates to Dupilumab in Chronic Urticaria Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dupilumab in Chronic Urticaria Clinical Trial page.